Application YC di Equator Therapeutics
Equator Therapeutics ha partecipato a Y Combinator nel batch Winter 2020 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Winter 2020
- Settore
- HealthcareTherapeutics
- Dimensione team
- 2
- Stato
- Active
- Lanciata
- 2020
Founder
Liliya KhasinFounder
Yuriy KirichokFounder
Jonah SinickFounder
Cosa fa Equator Therapeutics
We are developing a drug to increase metabolism and burn calories without exercise. Obesity and type 2 diabetes have reached epidemic proportions. There are 2.2B overweight people and 500M people with type 2 diabetes worldwide, and these numbers increase drastically every year. Existing drugs are not effective enough to reverse the trend. Our drug can solve this problem, because it addresses the root cause of metabolic disorders - the imbalance between caloric intake and expenditure. Our drug will target mitochondria - the powerhouse of the cell - to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.
Application YC di Equator Therapeutics, ricostruita
Domanda per Y Combinator
Equator Therapeutics, batch Winter 2020. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Equator Therapeutics
Drug to burn calories and increase metabolism
We are developing a drug that activates a natural protein in mitochondria to generate heat, burning calories and increasing metabolism without exercise. Our approach targets the root cause of obesity and type 2 diabetes by shifting the balance between calorie intake and expenditure through mitochondrial heat production, overcoming the side effects of previous methods.
We live in San Francisco and plan to keep the company based here after YC.
San Francisco is where the team already lives and works, giving us access to biotech talent and resources critical for developing a therapeutic drug.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di Equator Therapeutics?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Equator Therapeutics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Equator Therapeutics si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva Equator Therapeutics?
Equator Therapeutics apparteneva al batch Winter 2020 di Y Combinator.
Chi ha fondato Equator Therapeutics?
Equator Therapeutics è stato fondato da Liliya Khasin, Yuriy Kirichok, Jonah Sinick.
Cosa fa Equator Therapeutics?
We are developing a drug to burn calories and increase metabolism…
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Equator Therapeutics, e di ogni altro batch YC, è in YC Insights.
Più startup YC come Equator Therapeutics
